Apr 18, 2022
Brian Mast- Amount
- $1,001 to $15,000
- Filed
- May 9, 2022
Congress ticker disclosure profile
As of August 1 at 7:12 PM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference TLRY. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
10
Member filers
2
Disclosed ranges
$16K
Most active member desks
Balanced
Latest trade Apr 18, 2022
Apr 18, 2022
Brian MastMay 3, 2021
Brian MastMay 3, 2021
Brian MastFeb 12, 2021
John A. YarmuthFeb 10, 2021
Brian MastFeb 9, 2021
Brian MastNov 6, 2020
Brian MastNov 5, 2020
John A. YarmuthFeb 4, 2019
Brian MastJan 18, 2019
Brian Mast| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| Apr 18, 2022 | Brian Mast | Sell | $1,001 to $15,000 | May 9, 2022 | Open card |
| May 3, 2021 | Brian Mast | Exchange | Receipt pending ingestion | Date not disclosed | Receipt pending ingestion |
| May 3, 2021 | Brian Mast | Exchange | $1,001 to $15,000 | Oct 5, 2022 | Open card |
| Feb 12, 2021 | John A. Yarmuth | Buy | Receipt pending ingestion | Feb 19, 2021 | Open card |
| Feb 10, 2021 | Brian Mast | Sell | Receipt pending ingestion | Mar 17, 2021 | Open card |
| Feb 9, 2021 | Brian Mast | Sell | Receipt pending ingestion | Mar 17, 2021 | Open card |
| Nov 6, 2020 | Brian Mast | Buy | Receipt pending ingestion | Dec 1, 2020 | Open card |
| Nov 5, 2020 | John A. Yarmuth | Buy | Receipt pending ingestion | Nov 15, 2020 | Receipt pending ingestion |
| Feb 4, 2019 | Brian Mast | Sell | Receipt pending ingestion | Mar 12, 2019 | Open card |
| Jan 18, 2019 | Brian Mast | Buy | Receipt pending ingestion | Feb 5, 2019 | Open card |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 2 of 10 filed rows include disclosed amount ranges (20%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.